Way2Wealth's IPO report on Chemcon Speciality Chemicals
Incorporated on December 15, 1988, Chemcon Speciality Chemicals Ltd (Chemcon) is a manufacturer of specialised chemicals, such as Hexamethyldisilazane / Hexamethyldisilane (HMDS) and Chloromethyl Isopropyl Carbonate (CMIC) which are predominantly used in the pharmaceuticals industry (Pharmaceutical Chemicals), and inorganic bromides, namely Calcium Bromide, Zinc Bromide and Sodium Bromide, which are predominantly used as completion fluids in the oilfields industry (Oilwell Completion Chemical). The company’s has 7 manufacturing plants at a single location – Manjusar in Gujarat, having volumetric reactor capacity of 374kl as of July 2020.
Valuation and Outlook
We believe company’s specialised product offerings, increasing demand for the products, superior return ratios and stable asset quality justifies its valuation. We thus advise investors with a long-term investment horizon to SUBSCRIBE to the issue.
For all IPO stories, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.